Impact of comorbidities on anti-TNFα response and relapse in patients with inflammatory bowel disease: the VERNE study
Impact of comorbidities on anti-TNFα response and relapse in patients with inflammatory bowel disease: the VERNE study is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Impact of comorbidities on anti-TNFα response and relapse in patients with inflammatory bowel disease: the VERNE study have?
Impact of comorbidities on anti-TNFα response and relapse in patients with inflammatory bowel disease: the VERNE study has 11 citations in the OpenAlex counts ScholarIQ stores.
When was Impact of comorbidities on anti-TNFα response and relapse in patients with inflammatory bowel disease: the VERNE study published?
Impact of comorbidities on anti-TNFα response and relapse in patients with inflammatory bowel disease: the VERNE study has 2020 year in the ScholarIQ index.
What is the open-access status of Impact of comorbidities on anti-TNFα response and relapse in patients with inflammatory bowel disease: the VERNE study?
Impact of comorbidities on anti-TNFα response and relapse in patients with inflammatory bowel disease: the VERNE study has gold oa status in the ScholarIQ index.
What is the DOI of Impact of comorbidities on anti-TNFα response and relapse in patients with inflammatory bowel disease: the VERNE study?
The DOI for Impact of comorbidities on anti-TNFα response and relapse in patients with inflammatory bowel disease: the VERNE study is on the source record.
What is the PMID of Impact of comorbidities on anti-TNFα response and relapse in patients with inflammatory bowel disease: the VERNE study?
The PMID for Impact of comorbidities on anti-TNFα response and relapse in patients with inflammatory bowel disease: the VERNE study is on the source record.
What is the OpenAlex record for Impact of comorbidities on anti-TNFα response and relapse in patients with inflammatory bowel disease: the VERNE study?
The OpenAlex for Impact of comorbidities on anti-TNFα response and relapse in patients with inflammatory bowel disease: the VERNE study is on the source record.